A Comparison Study of Some Biochemical Markers in Type 2 Diabetic Patients in Kerbala Between those Who are Non-Smokers and do Exercise and those who are Smokers and don’t Exercise

Abstract

Diabetes is a comprehensive term for a number of metabolic diseases that affect the body's ability to control blood glucose levels. Insulin is produced in the pancreas and helps to metabolize glucose for energy. Diabetes occurs when insulin production is weak. The current study was to examine the effect of smoking and exercise on biochemicals for type 2 diabetics Kerbala. Patients and Methods: Group A: Consists of 20 type 2 patients with diabetes, were smokers, and did not exercise and were treated by metformin. Group B consists of 20 patients of type 2 diabetes, non-smokers, exercise and metformin treatment. Control group: Normal healthy individuals for comparison, 20 healthy people participated in this study. Type 2 DM patients have controls characterized by age, fasting plasma glucose and fasting personal fasting Lipid profile: Comparison of the TG in different groups with control shows that all groups [control (TSC:4.08±0.615,TG: 1.05±0.314),group A(TSC: 5.01±1.479,TG: 3.51±1.961) and group B(TSC: 4.55±1.161,TG: 2.23±1.654) ](unites in mmol/L) have a significant differences ,while for TSC there is a significant difference between all groups except with the group B. Fasting blood glucose: Comparison of the parameters in all groups[control(FBG:5.853±0.662) ,group A(FBG: 10.893±1.441) and group B(FBG: 9.042±1.071) ](unites in mg/dL) shows that there is significant difference in the level of glucose. Exercise and exercise result in non smoking smoking results in controlling high blood sugar, dyslipidemia and effects of optimizing metformin in controlling blood sugar in type 2 diabetic patients.